Healthcare’s sales culture has long been shaped by competitive pressure, consolidation and the perceived need to protect market share. Across pharmaceuticals, medical devices, hospital systems, insurers, health IT firms, digital health startups and post-acute providers, hospitality became embedded in commercial strategy. Sales retreats, sponsorships, sporting events and elaborate dinners were framed as relationship-building and brand awareness, eventually becoming accepted as standard practice. Over time, what began as occasional gestures evolved into routine expectation. Differentiation escalated into spectacle, and norms solidified quietly across sectors. The focus shifted from whether such practices served patients to whether opting out would carry a competitive penalty. As financial pressures intensify and public scrutiny grows, longstanding assumptions about what constitutes the “cost of doing business” are facing renewed examination.
How Sales Culture Became Embedded
The current sales environment did not emerge from excess alone but from mounting pressure. As markets grew more crowded and consolidation accelerated, access and familiarity became critical. Sales teams were not only pursuing new contracts but also defending existing relationships in highly competitive landscapes. Hospitality offered a means of creating visibility and differentiation in environments where products and services often appeared comparable.
Over time, the scale and scope of these practices expanded. What began as limited hospitality became expected participation. Pharmaceutical conferences became more elaborate. Device manufacturers layered additional perks into physician engagement strategies. Health systems adopted similar norms in their interactions with vendors and partners. Insurers mirrored these approaches with brokers. Even digital health organisations, initially positioned as a cultural reset, replicated comparable strategies once capital and scale increased.
Must Read: Employer Health Priorities in 2026: Costs, Pharmacy and AI
As these patterns spread, each segment reinforced the others. The question gradually shifted from strategic necessity to competitive risk. The possibility of abstaining from elaborate hospitality came to be viewed as a potential disadvantage rather than a principled choice. Norms solidified not through explicit endorsement but through repetition and mutual reinforcement across the ecosystem.
Transparency Gaps and Uneven Standards
Within this environment, inconsistencies have become more visible. Physicians operate under stringent disclosure requirements related to gifts, meals, travel, consulting fees and honoraria. These payments are recorded in a publicly searchable database, reflecting a policy stance that even the appearance of influence warrants scrutiny.
Beyond clinical practice, however, comparable transparency is less evident. Executives, intermediaries, vendors and partners may participate in forms of entertainment that would be unacceptable for clinicians, without equivalent disclosure obligations. While not necessarily intentional, the disparity in oversight creates tension.
Healthcare policy acknowledges that influence matters. If scrutiny is justified for clinicians, limiting it to one segment of the ecosystem raises questions. The divergence in standards is increasingly difficult to defend, particularly in a sector that emphasises accountability and trust. As awareness of these inconsistencies grows, so too does pressure to reassess longstanding practices that have escaped equivalent examination.
Questioning Value in a Time of Constraint
Defenders of expansive hospitality argue that relationships are central to healthcare and that such practices help cultivate them. The importance of relationships is not in dispute. What remains uncertain is whether luxury and spectacle meaningfully contribute to those relationships or simply persist through inertia.
Every allocation of funds reflects prioritisation. Resources directed toward entertainment and large-scale events are not available for alternative uses. Individually, such expenditures may appear marginal. Collectively, they become more consequential, particularly at a time when patients face rising costs, clinicians experience strain and organisations confront financial and reputational pressures.
Against this backdrop, some organisations have begun to reassess their approach. Adjustments may include scaling back partner entertainment, selecting more modest venues and emphasising informational gatherings over spectacle. The focus shifts toward clarity and substance rather than experience design. These changes are not necessarily framed as moral corrections but as deliberate operational choices aligned with evolving expectations.
Culture shifts gradually. It is shaped less by declarations than by consistent decisions about what to fund and what to forgo. As margins tighten and scrutiny intensifies, practices once considered benign invite closer examination.
Healthcare is entering a period defined by tighter margins, greater accountability and heightened public expectations. Many historical practices emerged within specific competitive contexts that once made them appear reasonable. Those contexts are evolving. The characterisation of luxury hospitality as an unavoidable cost of doing business is becoming harder to sustain. The direction of change will not be determined by rhetoric but by everyday organisational decisions. How leaders allocate resources, define acceptable norms and respond to scrutiny will shape the next phase of healthcare’s commercial culture.
Source: Forbes
Image Credit: iStock
